U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07396844) titled 'The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers' on Feb. 02.
Brief Summary: This is a single dose, randomized, open-label, two-way crossover study to investigate the food-effect bioavailability of the fixed-dose combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg in healthy volunteers under fasting and fed conditions.
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy
Fasting
Fed
Intervention:
DRUG: Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg
All participants will receive a single ...